PHP
NKTX icon

Parkman Healthcare Partners’s Nkarta NKTX Stock Holding History

Parkman Healthcare Partners’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-252,028
Closed -$2.72M – 105
2024
Q1 		$2.72M Buy
+252,028
New +$2.62M 0.33% 75

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parkman Healthcare Partners's NKTX Position: Q2 2024 in Review

Parkman Healthcare Partners sold out of Nkarta (NKTX) in Q2 2024, closing a stake of 252,028 shares — an estimated $2.72M sold.

Parkman Healthcare Partners first reported a position in NKTX in Q1 2024 and held it in 1 quarter. The position peaked at $2.72M in Q1 2024. 112 funds tracked by Wall St. Rank hold NKTX as of Q2 2024.

  • Parkman Healthcare Partners reported no remaining Nkarta position as of Q2 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 252,028 Nkarta shares in Q2 2024, an estimated $2.72M.
  • Parkman Healthcare Partners first reported a position in Nkarta in Q1 2024 and held it in 1 quarter.
  • Parkman Healthcare Partners's Nkarta position peaked at $2.72M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Nkarta as of Q2 2024.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.